Okolicsanyi L, Lirussi F, Nassuato G, Orlando R, Bussolon R, Dal Brun G
Naunyn Schmiedebergs Arch Pharmacol. 1980 Aug;313(2):171-4. doi: 10.1007/BF00498576.
Sodium cholate was infused with or without Rifamycin SV in rats in order to determine the site of interference of the drug on hepatic bile salt metabolism. Both compounds were administered at rates such as to saturate their respective maximal excretory capacities. When Rifamycin SV was given, bile acid uptake and excretion significantly decreased, with a significant reduction of the percent of conjugated bile salts in bile. Rifamycin SV neither modified bile flow nor affected the correlation between bile flow and bile salt excretion. These data suggest that the antibiotic interferes with the three main steps of hepatic bile acid metabolism. The cholestatic effect and the modification of biliary bile salt output produced by Ryfamycin SV in rats, could be of clinical relevance.
在大鼠中输注胆酸钠,同时或不联合利福霉素SV,以确定该药物对肝脏胆汁盐代谢的干扰位点。两种化合物均以使其各自最大排泄能力饱和的速率给药。给予利福霉素SV时,胆汁酸摄取和排泄显著降低,胆汁中结合胆汁盐的百分比显著降低。利福霉素SV既不改变胆汁流量,也不影响胆汁流量与胆汁盐排泄之间的相关性。这些数据表明,该抗生素干扰肝脏胆汁酸代谢的三个主要步骤。利福霉素SV在大鼠中产生的胆汁淤积作用和胆汁胆汁盐输出的改变可能具有临床意义。